Coldstream Capital Management Inc Pliant Therapeutics, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 3,061 shares of PLRX stock, worth $4,866. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,061Holding current value
$4,866% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PLRX
# of Institutions
161Shares Held
57.4MCall Options Held
258KPut Options Held
470K-
Deep Track Capital, LP Greenwich, CT5.4MShares$8.59 Million0.25% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$7.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$5.3 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.2MShares$5.08 Million1.61% of portfolio
-
Chi Advisors LLC New York, NY3.01MShares$4.79 Million25.76% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $77.4M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...